G26C4H1P00K — CHP GHK-Cu
Vendor COACHP | GHK-Cu, last activity 1 month ago
3 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 100 mg. Janoshik weighed 109.6 mg — 10% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
18 units
on a U-100 insulin syringe, for 10 mg
Going by the label you would draw 20 units — which from this vial is actually 11 mg, not 10 mg.
- The vial holds dry powder: 109.6 mg of GHK-Cu, as weighed.
- Water spreads that powder evenly through the liquid: 109.6 mg ÷ 2 ml = 54.8 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 548 mcg.
- Your dose divided by that: 10 mg ÷ 548 mcg = 18 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
Tirzepatide, same vendor
1 community mention, no summary yet
SPB
2 community mentions, no summary yet
TB-500 (Thymosin Beta 4), same vendor
1 community mention, no summary yet
Cagrilintide, same vendor
Tirzepatide, same vendor
Community Intelligence
- 2 concern reports involving SJ26LY-1-01
- 1 concern report involving HK50KP200701
- 1 concern report involving HK50-0522
Reported against other CHP GHK-Cu batches, not this one.
Activity
No community activity tracked yet.
Vendor
CHP